Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy

A radiosensitizer and compound technology, applied in the field of brain tumors and head and neck tumors, can solve problems such as ineffectiveness

Inactive Publication Date: 2006-10-18
BROOKHAVEN SCI ASSOCS
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although radiosensitizers for hypoxic cells have been developed, most have been clinically shown to be ineffective

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
  • Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
  • Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] In this example, CuTCPBr was synthesized from CuTCPH by the bromination method. CuTCPH (200 mg, 0.146 mmol) was dissolved in a 1:1 mixed solvent of chloroform and carbon tetrachloride (70 mL). While stirring the mixture, bromine (240 μL, 4.6 mmol) dissolved in the same mixed solvent (20 mL) was added over 30 minutes. Pyridine (0.6 mL) dissolved in a mixed solvent (15 mL) was added over 30 minutes, followed by stirring at room temperature overnight. Excess bromine was removed the next day with 20% aqueous sodium metabisulfite (40 mL). The reaction mixture was worked up, and the organic layer was separated and washed 3 times with water. The organic layer was then dried over anhydrous sodium sulfate, and the solvent was removed in vacuo. The desired product was purified by preparative thin layer chromatography. The product weighs 176 mg (0.088 mmol), and the yield is 60%.

[0062] Compounds were identified by optical absorption spectroscopy and fast atom bombardment m...

Embodiment 2

[0064] Thoracic and back tumors

[0065] Five BALB / c mice implanted subcutaneously with EMT-6 breast cancer in the chest and back were injected intraperitoneally (ip) six times with a total dose of CuTCPBr of 186 μg / g body weight in 2 days. Four days after the last injection, the mice were euthanized and the mean boron concentration (μg / g wet tissue) of the different tissues was determined. The results are shown in Table 1.

[0066] sample

[0067] No somatic or behavioral toxic effects on mice were observed during and after porphyrin administration. Necropsy revealed that all tissues were normal.

Embodiment 3

[0069] leg tumor

[0070] In this example, BALB / c mice with subcutaneous EMT-6 leg tumors were administered 156 μg CuTCPBr / g body weight within 2 days, with a volume of 0.01 mL / g body weight / injection. Next, the boron concentration (μg / g) in various tissues of BALB / c mice was measured, and the results are shown in Table 2.

[0071] last note

days since ejaculation

number of mice

the tumor

Blood

the brain

Ear

liver

2

6

24±11

0.2±0.1

0±0.1

1±1

271±40

5

5

13±6

0.1±0.1

0.6±1

0.6±0.7

308±40

[0072] Notably, boron concentrations in leg tumors were significantly lower than those in thoracic and back tumors. There is larger vasculature around the thorax and back compared to the legs, which may be a factor. However, when it was CuTCPH, the boron concentration in the leg tumors was 30% highe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention covers radiosensitizers containing as an active ingredient halogenated derivatives of boronated porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron-capture therapy and photodynamic therapy. The present invention also covers methods for using these radiosensitizers in tumor imaging and cancer treatment.

Description

[0001] This invention was made with U.S. Government support under Contract No. DE-AC02-98CH10886 at the U.S. Department of Energy by Brookhaven National Laboratory. The US Government has certain rights in this invention. Background technique [0002] The present invention relates to radiosensitizers and methods of using the radiosensitizers to treat malignant tumors, especially brain tumors and head and neck tumors. [0003] Radiosensitizers are substances that sensitize cancer cells to the effects of radiation therapy, thereby increasing the effects of radiation doses. The presence of hypoxic cells in tumors is the biggest problem when treating cancer with radiation therapy. Radiation and existing chemotherapy techniques are ineffective against oxygen-deprived tumor cells. In contrast to cancerous tumors, normal tissues do not have any hypoxic cells. Therefore, treating cancer with radiation therapy would be more effective after increasing the radio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/409C07D487/22C07F5/02A61P35/00A61N5/10A61K31/69A61K41/00A61K51/00A61K51/04
CPCA61K31/409A61K41/0038A61K41/0095A61K51/0485C07D487/22A61P35/00
Inventor M·缪拉D·N·斯拉特金
Owner BROOKHAVEN SCI ASSOCS